Search Orphan Drug Designations and Approvals
-
Generic Name: | ezogabine |
---|---|
Date Designated: | 06/21/2018 |
Orphan Designation: | Treatment of KCNQ2 epileptic encephalopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Xenon Pharmaceuticals, Inc. 200-3650 Gilmore Way Burnaby Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
-